Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
4.450
+0.020 (0.45%)
At close: Jan 21, 2025, 4:00 PM
4.500
+0.050 (1.12%)
After-hours: Jan 21, 2025, 6:38 PM EST
Terns Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
66
Market Cap
377.98M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
TERN News
- 13 days ago - Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 19 days ago - Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 6 weeks ago - Terns's stock soars as analysts cheer leukemia data — and predict more gains - Market Watch
- 7 weeks ago - Terns Pharma broadens beyond obesity drugs with upbeat data in leukemia trial - Market Watch
- 2 months ago - Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga
- 2 months ago - Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors - GlobeNewsWire
- 2 months ago - RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking. - Market Watch
- 4 months ago - Terns Pharmaceuticals: Obesity Advancement Continues With Other Q1 2025 Program Catalyst - Seeking Alpha